#pancreatic — Wednesday, September 16, 2026 (1 items)
| 0 | ℹ |
Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer.
(linkinghub.elsevier.com)
|
Cancer Cell 2026-09-16 | #immunotherapy #oncology #pancreatic #clinical trial #kras |